Full Text View
Tabular View
No Study Results Posted
Related Studies
Customized Choice of Oral P2Y12 Receptor Blocker (GENE-MATRIX)
This study is currently recruiting participants.
Verified November 2012 by Italian Society of Invasive Cardiology
Study NCT01477775   Information provided by Italian Society of Invasive Cardiology

First Received on October 27, 2011.   Last Updated on November 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Coronary Syndrome
Coronary Angioplasty
More general conditions related to this trial
Angina Pectoris
Cardiovascular Diseases
Chest Pain
Heart Diseases
Myocardial Ischemia
Pain
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
Oral P2Y12 receptor blocker
Additional drug interventions recognized in this trial
Clopidogrel
More general drug interventions related to this trial
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Purinergic Agents
Purinergic Antagonists
Purinergic P2 Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Therapeutic Uses
Sponsors listed in this trial
Italian Society of Invasive Cardiology
Eustrategy


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services